QLUPOD AG: Successful Launch of Apps and Expansion of Customer Service

A New Milestone for Digital Health Care

QluPod

[ Fotos /PDFs ]

Herisau (pta014/27.03.2025/10:26 UTC+1)

Herisau, Switzerland – March 27, 2025 – Qlupod AG (www.qlupod.com) is pleased to

announce that after extensive testing and further optimization, its three innovative apps –

QluApp, QluDoc, and QluCare – are now officially available in the Android and Apple Stores.

These three apps, which were completed at the end of 2024, enable users to monitor and

share their health data in real-time. With this, Qlupod takes another important step forward in

the development of digital health care.

App Availability and New Goals

"The availability of our apps marks a significant turning point for Qlupod," said Nikola

Trajanov, Interim CEO and Partner of Qlupod AG. "After the intense testing phase, we are

excited to not only drive the sales of our devices but also invite doctors and care facilities to

take advantage of the benefits of our apps for patient care."

With the launch of the apps, Qlupod AG will now focus on further expanding and enhancing

the app's features. "We see great potential in continuously developing our apps to better

meet the needs of doctors and care facilities. These institutions need to optimize their

workflows while ensuring the highest quality care for their patients – this is exactly where our

solutions can make a difference," Trajanov continued.

New Customer Care Center for Better Service

To accommodate the growing demand and ensure optimal support for new users (including

doctors and care facilities), Qlupod AG will establish a Customer Care Center. This will be

an essential component for customer service, offering both end-users and medical

professionals direct and efficient support. The center will make the transition to digital health

monitoring with the QluPod even easier for all users.

QluPod as a Solution for Preventative and Therapeutic Applications

Qlupod AG emphasizes that the QluPod, a medically certified and tested device, can

measure the key vital signs typically checked during a physical examination by a general

practitioner: temperature, pulse, EKG, blood pressure, and blood oxygen levels. This makes

the device an important solution for both preventive health monitoring and ongoing care for

patients as part of existing therapies.

"Whether for preventive measures or managing ongoing treatments, the QluPod provides a

flexible and accurate way to monitor health data and share it directly with the attending

doctor or caregiver," explained Nikola Trajanov. "We believe that integrating the QluPod into

existing health systems can offer significant added value for all parties, especially in terms of

reducing costs and improving patient care."

Partnerships with Health Insurers and Healthcare Providers

Qlupod AG sees significant potential in collaborating with health insurers and healthcare

providers. The QluPod, in particular, could serve as a technological bridge between patients,

doctors, and care teams, improving communication and care delivery. "Our solution could

play a key role in enhancing the quality of patient care while simultaneously reducing costs in

the healthcare system," added Trajanov. "We invite all interested health insurers, Spitex

services, and care facilities to reach out to us and explore the possibilities of integrating our

solution into their systems."Future Outlook

With the successful launch of the apps and the expansion of customer service, Qlupod AG is

now at the threshold of a new growth phase. "We are confident that our products and

services will make a significant contribution to digital healthcare. The next big challenge will

be expanding our partnerships and establishing our solutions more widely in the market,"

concluded Nikola Trajanov.

About Qlupod:

Qlupod AG is a start-up company in the field of telemedicine and develops innovative solutions

to make patient care efficient and cost-effective. With the QluPod device and the associated

software, the company is endeavouring to shape the future of healthcare. The offering is aimed

at hospitals, care facilities, medical professionals and private individuals who want to monitor

their health independently.

For more information about Qlupod AG and our products, please visit our website at

www.qlupod.com.

Disclaimer:

This publication constitutes neither an offer to sell nor a solicitation to buy securities. Insofar

as this document contains forward-looking statements, these do not represent facts and are

characterised by the words "expect", "believe", "estimate", "intend", "aim", "assume" and

similar expressions. These statements express the intentions, opinions or current expectations

and assumptions of Qlupod AG and are based on current plans, estimates and forecasts which

Qlupod AG has made to the best of its knowledge, but do not claim to be correct in the future.

Forward-looking statements are subject to risks and uncertainties that are difficult to predict

and are generally beyond the control of Qlupod AG. It should be noted that actual events or

developments may differ materially from the events and developments expressed or implied

by such forward-looking statements.

(end)

Emitter:	QLUPOD AG Bahnhofstrasse 23 9100 Herisau Switzerland
Contact Person:	Nikola Trajanov
Phone:	+41 71 510 05 45
E-Mail:	ir@qlupod.com
Website:	qlupod.eu
ISIN(s):	CH1222316429 (Share)
Stock Exchange(s):	-
Other Stock Exchanges:	Regelmaessige Kursfeststellung Schweiz